In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...
Stephen Freedland, MD, of Cedars-Sinai, discussed enzalutamide and leuprolide's potential to improve overall survival without ...
Precipitation and humidity can render a standard paper target unusable in only seconds, which is what makes Rite In The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results